Literature DB >> 7387164

Plasma androgens after a single oral dose of testosterone undecanoate.

G Geere, J Jones, S M Atherden, D B Grant.   

Abstract

Total plasma androgens (PA) were measured in 9 hypogonadal males aged between 13 and 21 1/2 years after a single oral dose of testosterone undecanoate (TU). With the exception of one patient, all showed a rise in PA with peak values between 7.7 and 38.0 nmol/l at 2 to 7 hours. A further patient aged 15.7 years who was given an 80-mg dose had a peak PA level of 71.2 nmol/l. In all patients PA returned to basal levels at 24 hours. In 4 patients plasma testosterone and dihydrotestosterone were measured, both rose after oral TU, and relatively high plasma dihydrotestosterone values were obtained. While these results indicate that TU is effective in young people, the very high peak androgen levels found in several of them after 40 mg TU suggest that this dose may be excessive in patients in whom growth is not complete.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387164      PMCID: PMC1626771          DOI: 10.1136/adc.55.3.218

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  A study of the androgen receptors in a variety of androgen-sensitive tissues.

Authors:  W I Mainwaring; F R Mangan
Journal:  J Endocrinol       Date:  1973-10       Impact factor: 4.286

2.  Testosterone undecanoate: a new orally active androgen.

Authors:  C Hirschhäuser; C R Hopkinson; G Sturm; A Coert
Journal:  Acta Endocrinol (Copenh)       Date:  1975-09

3.  Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.

Authors:  E Nieschlag; J Mauss; A Coert; P Kićović
Journal:  Acta Endocrinol (Copenh)       Date:  1975-06

4.  Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep.

Authors:  R M Boyar; R S Rosenfeld; S Kapen; J W Finkelstein; H P Roffwarg; E D Weitzman; L Hellman
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

  4 in total
  5 in total

1.  Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

Authors:  L Tax
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

Review 2.  Treatment of the short, sexually immature adolescent boy.

Authors:  C J Kelnar
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

3.  Pharmacokinetics of sex steroids in patients with beta thalassaemia major.

Authors:  M Katz; V De Sanctis; C Vullo; B Wonke; H H McGarrigle; B Bagni
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

4.  A double blind, placebo controlled study of the effects of low dose testosterone undecanoate on the growth of small for age, prepubertal boys.

Authors:  D C Brown; G E Butler; C J Kelnar; F C Wu
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

5.  Testosterone disrupts human collaboration by increasing egocentric choices.

Authors:  Nicholas D Wright; Bahador Bahrami; Emily Johnson; Gina Di Malta; Geraint Rees; Christopher D Frith; Raymond J Dolan
Journal:  Proc Biol Sci       Date:  2012-02-01       Impact factor: 5.349

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.